Domantis have several drug 'leads' - hardly a drug portfolio.
It is quite possible that Domantis will develop drugs from their technology - as I said - this is a strong company.
However, that does not change any of the advantages that Phylogica have over Domanits.
And it certainly does not mean that Domantis will make Phylogica's technology redundant.
Drugs that treat and cure disease come from many different sources.
- Forums
- ASX - By Stock
- PYC
- is there news coming
is there news coming, page-20
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.0¢ | $296.0K | 2.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 793740 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 281215 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 793740 | 0.100 |
3 | 716341 | 0.099 |
6 | 485204 | 0.098 |
2 | 29485 | 0.097 |
2 | 255000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 281215 | 6 |
0.110 | 398824 | 4 |
0.115 | 1306852 | 9 |
0.120 | 669510 | 6 |
0.125 | 255000 | 3 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online